Beats Biogen Quarterly Estimates as Newer Drugs Fuel Growth
July 29 Biogen reported second-quarter profit and revenue that topped Wall Street estimates on Wednesday, driven by strong demand for its rare-disease medicines, while sales of its legacy multiple sclerosis drugs stayed under pressure. Investors are closely watching whethe